Section Arrow
INKT.NASDAQ
- MiNK Therapeutics Inc
Quotes are at least 15-min delayed:2025/11/19 08:24 EST
Pre Market
Last
 10.94
-0.37 (-3.27%)
Bid
10.75
Ask
13.89
High 11.5 
Low 10.94 
Volume 13 
Regular Hours
Last
 11.31
-0.69 (-5.75%)
Day High 
11.87 
Prev. Close
12 
1-M High
15.35 
Volume 
46.77K 
Bid
10.75
Ask
13.89
Day Low
10.7948 
Open
11.81 
1-M Low
12 
Market Cap 
55.21M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 13.19 
20-SMA 13.7 
50-SMA 14.25 
52-W High 76 
52-W Low 4.5601 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.80/-3.91
Enterprise Value
60.13M
Balance Sheet
Book Value Per Share
-5.48
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CANFCan-Fite BioPharma Ltd0.3801+0.0181+5.00%-- 
Pre Market 0.34 -0.0401 -10.55%
ASBPAspire Biopharma Holdings Inc.0.1057+0.0144+15.77%-- 
Pre Market 0.0999 -0.0058 -5.49%
OLMAOlema Pharmaceuticals20.14+11.62+136.38%-- 
Pre Market 19.48 -0.66 -3.28%
CMNDClearmind Medicine0.2164-0.0605-21.85%0.16PE
Pre Market 0.2109 -0.0055 -2.54%
APLTApplied Therapeutics0.2984+0.0142+5.00%-- 
Pre Market 0.2755 -0.0229 -7.67%
Quotes are at least 15-min delayed:2025/11/19 08:24 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.